Metronomic cyclophosphamide with bevacizumab provides disease stabilization in patients with advanced uterine cancer

• We present two cases of advanced uterine cancer that were treated with the combination of metronomic cyclophosphamide and bevacizumab. • Targeting angiogenesis can provide disease control in patients with advanced uterine cancer. • Randomized controlled trials comparing metronomic and conventional...

Descripción completa

Detalles Bibliográficos
Autores principales: Alagkiozidis, Ioannis, Lozano, Melissa, Devraj, Mithun, Lee, Yi-Chun, Abulafia, Ovadia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2015
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4442644/
https://www.ncbi.nlm.nih.gov/pubmed/26076153
http://dx.doi.org/10.1016/j.gore.2014.12.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4442644/
https://www.ncbi.nlm.nih.gov/pubmed/26076153
http://dx.doi.org/10.1016/j.gore.2014.12.004

Ejemplares similares